Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd
688336
Rankning i aktier
#3774
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd functions as a... Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd functions as a biopharmaceutical enterprise operating in China. This company is thoroughly engaged in the full lifecycle of antibody-based medicines, from their initial research and development to their production and subsequent market introduction. Its current portfolio includes YISAIPU, a tumor necrosis factor inhibitor utilized for treating rheumatic ailments; Xenopax, a recombinant humanized anti-CD25 monoclonal antibody delivered via injection; and Cipterbin, an anti-HER2 monoclonal antibody. Furthermore, the organization is actively progressing novel treatments designed for autoimmune disorders, various cancers, and other health issues. Established in 2002, its main offices are situated in Shanghai, China.
Aktiekurs
$4.87
Marknadsvärde
$4.36B
Förändring (1 dag)
-5.47%
Förändring (1 år)
-15.62%
Land
CN
Handel Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336)
Kategori
Healthcare
Historik för aktiesplit för Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336)
Aktien Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (symbol: 688336) har genomgått totalt 1 aktiesplitar.
Den senaste spliten skedde den Jun 18, 2026.
En 688336-aktie köpt före Jun 18, 2026 motsvarar nu 1.45 688336-aktier.
Den senaste spliten skedde den Jun 18, 2026.
En 688336-aktie köpt före Jun 18, 2026 motsvarar nu 1.45 688336-aktier.
Lista över aktiesplitar
| År | Split | Multipel | Kumulativ multipel |
|---|---|---|---|
| 2026-06-18 | 29:20 | x1.45 | x1.45 |
Aktiesplitar för liknande företag eller konkurrenter
| Företag | Antal aktiesplitar | Kumulativ multipel | Land |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 1 | x100 |
BE
|
|
| 0 | - |
NL
|
